Clinical Trial Update: HD-Idarubicin/Etoposide Intensified Conditioning Regimen Allo-HSCT for Adult ALL [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on an intensified conditioning regimen using high-dose idarubicin and etoposide before allogeneic hematopoietic stem cell transp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Etoposide (Etoposide)
• HD-Idarubicin (idarubicin)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Acute Lymphoblastic Leukemia | Phase 4 | Status: UNKNOWN